N-[4-(4-methoxyphenyl)-4-methyl-2,5-dioxoimidazolidin-1-yl]-2-[4-(morpholine-4-carbonyl)piperazin-1-yl]acetamide

C22H30N6O6 — CID 55511314

IUPACN-[4-(4-methoxyphenyl)-4-methyl-2,5-dioxoimidazolidin-1-yl]-2-[4-(morpholine-4-carbonyl)piperazin-1-yl]acetamide
SMILESCOc1ccc(C2(C)NC(=O)N(NC(=O)CN3CCN(C(=O)N4CCOCC4)CC3)C2=O)cc1
InChIInChI=1S/C22H30N6O6/c1-22(16-3-5-17(33-2)6-4-16)19(30)28(20(31)23-22)24-18(29)15-25-7-9-26(10-8-25)21(32)27-11-13-34-14-12-27/h3-6H,7-15H2,1-2H3,(H,23,31)(H,24,29)
InChIKeyCRAOCBHFLQWBCY-UHFFFAOYSA-N
MW474.52 g/mol
LogP-0.44
Rot. Bonds5

About N-[4-(4-methoxyphenyl)-4-methyl-2,5-dioxoimidazolidin-1-yl]-2-[4-(morpholine-4-carbonyl)piperazin-1-yl]acetamide

N-[4-(4-methoxyphenyl)-4-methyl-2,5-dioxoimidazolidin-1-yl]-2-[4-(morpholine-4-carbonyl)piperazin-1-yl]acetamide (PubChem CID 55511314) has the molecular formula C22H30N6O6 and a molecular weight of 474.52 g/mol. Its IUPAC name is N-[4-(4-methoxyphenyl)-4-methyl-2,5-dioxoimidazolidin-1-yl]-2-[4-(morpholine-4-carbonyl)piperazin-1-yl]acetamide.

Molecular Properties

Compound NameN-[4-(4-methoxyphenyl)-4-methyl-2,5-dioxoimidazolidin-1-yl]-2-[4-(morpholine-4-carbonyl)piperazin-1-yl]acetamide
PubChem CID55511314
Molecular FormulaC22H30N6O6
Molecular Weight474.52 g/mol
Exact Mass474.22
IUPAC NameN-[4-(4-methoxyphenyl)-4-methyl-2,5-dioxoimidazolidin-1-yl]-2-[4-(morpholine-4-carbonyl)piperazin-1-yl]acetamide
SMILESCOc1ccc(C2(C)NC(=O)N(NC(=O)CN3CCN(C(=O)N4CCOCC4)CC3)C2=O)cc1
InChIInChI=1S/C22H30N6O6/c1-22(16-3-5-17(33-2)6-4-16)19(30)28(20(31)23-22)24-18(29)15-25-7-9-26(10-8-25)21(32)27-11-13-34-14-12-27/h3-6H,7-15H2,1-2H3,(H,23,31)(H,24,29)
InChIKeyCRAOCBHFLQWBCY-UHFFFAOYSA-N
XLogP-0.44
TPSA123.76 Ų
H-Bond Donors2
H-Bond Acceptors7
Rotatable Bonds5
Heavy Atoms34
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500474.52
LogP ≤ 5-0.44
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 107

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'hydantoin', 'substructure': 'N/A'}

Analyze N-[4-(4-methoxyphenyl)-4-methyl-2,5-dioxoimidazolidin-1-yl]-2-[4-(morpholine-4-carbonyl)piperazin-1-yl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[4-(4-methoxyphenyl)-4-methyl-2,5-dioxoimidazolidin-1-yl]-2-[4-(morpholine-4-carbonyl)piperazin-1-yl]acetamide?
The IUPAC name of N-[4-(4-methoxyphenyl)-4-methyl-2,5-dioxoimidazolidin-1-yl]-2-[4-(morpholine-4-carbonyl)piperazin-1-yl]acetamide (CID 55511314) is N-[4-(4-methoxyphenyl)-4-methyl-2,5-dioxoimidazolidin-1-yl]-2-[4-(morpholine-4-carbonyl)piperazin-1-yl]acetamide.
What is the SMILES notation for N-[4-(4-methoxyphenyl)-4-methyl-2,5-dioxoimidazolidin-1-yl]-2-[4-(morpholine-4-carbonyl)piperazin-1-yl]acetamide?
The canonical SMILES for N-[4-(4-methoxyphenyl)-4-methyl-2,5-dioxoimidazolidin-1-yl]-2-[4-(morpholine-4-carbonyl)piperazin-1-yl]acetamide is COc1ccc(C2(C)NC(=O)N(NC(=O)CN3CCN(C(=O)N4CCOCC4)CC3)C2=O)cc1.
What is the InChIKey of N-[4-(4-methoxyphenyl)-4-methyl-2,5-dioxoimidazolidin-1-yl]-2-[4-(morpholine-4-carbonyl)piperazin-1-yl]acetamide?
The InChIKey is CRAOCBHFLQWBCY-UHFFFAOYSA-N. The full InChI is InChI=1S/C22H30N6O6/c1-22(16-3-5-17(33-2)6-4-16)19(30)28(20(31)23-22)24-18(29)15-25-7-9-26(10-8-25)21(32)27-11-13-34-14-12-27/h3-6H,7-15H2,1-2H3,(H,23,31)(H,24,29).
What are the key properties of N-[4-(4-methoxyphenyl)-4-methyl-2,5-dioxoimidazolidin-1-yl]-2-[4-(morpholine-4-carbonyl)piperazin-1-yl]acetamide?
N-[4-(4-methoxyphenyl)-4-methyl-2,5-dioxoimidazolidin-1-yl]-2-[4-(morpholine-4-carbonyl)piperazin-1-yl]acetamide has a molecular weight of 474.52 g/mol, XLogP of -0.44, 5 rotatable bonds, 2 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for N-[4-(4-methoxyphenyl)-4-methyl-2,5-dioxoimidazolidin-1-yl]-2-[4-(morpholine-4-carbonyl)piperazin-1-yl]acetamide is sourced from PubChem (CID 55511314), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).